Recruiting
Phase 1

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Sponsor:

AIDS Malignancy Consortium

Code:

NCT05077527

Conditions

AIDS-Related Diffuse Large B-cell Lymphoma

AIDS-Related Non-Hodgkin Lymphoma

HIV Infection

Recurrent Diffuse Large B-Cell Lymphoma

Recurrent Grade 3b Follicular Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Axicabtagene Ciloleucel

Cyclophosphamide

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information